SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

OFFICIAL TRUMP (TRUMP) is a cryptocurrency and operates on the Solana platform. OFFICIAL TRUMP has a current supply of 999,998,811.032761 with 281,866,747.320393 in circulation. The last known price of OFFICIAL TRUMP is 1.57555883 USD and is down -1.93 over the last 24 hours. It is currently trading on 744 active market(s) with $126,884,732.61 traded over the last 24 hours. More information can be found at https://gettrumpmemes.com/.

Trump For President

Discussion centers on TRUMPs steep decline from its launch highs, with critics calling the politically branded meme coin a cash grab and pointing to losses among holders. Some traders say they are accumulating or anticipate a rebound, while others expect further declines.

Teradyne, Inc. engages in the development and sale of automatic test systems. It operates through the following business segments: Semiconductor Test, Robotics, and All Other. The Semiconductor Test segment designs, manufactures, and markets semiconductor test products and services. The Robotics segment includes operations related to the design, manufacturing, and marketing of collaborative robotic arms, autonomous mobile robots, and advanced robotic control software. The company was founded by Alexander V. d'Arbeloff and Nicholas DeWolf in 1960 and is headquartered in North Reading, MA.

Teradyne, Inc.

Teradyne is selling off despite a strong quarterly earnings beat as traders focus on cautious forward guidance, expected margin pressure and competitive concerns. The debate is whether robust AI-related chip-testing demand can outweigh the softer near-term outlook and rich valuation; some investors view the pullback as a buying opportunity.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regenerons third-quarter earnings beat, driven by growth in Dupixent and Eylea HD, fueled a sharp rally and a new 52-week high. Traders are largely upbeat about the breadth of growth, while noting that legacy Eylea sales and biosimilar competition remain risks.

Dogecoin (DOGE) is a cryptocurrency . Users are able to generate DOGE through the process of mining. Dogecoin has a current supply of 156,559,996,383.70523. The last known price of Dogecoin is 0.07552377 USD and is down -0.48 over the last 24 hours. It is currently trading on 1543 active market(s) with $337,365,256.17 traded over the last 24 hours. More information can be found at http://dogecoin.com/.

Dogecoin

Dogecoins weak, range-bound trading and repeated failure to break resistance dominate the discussion, with bearish technical commentary and holder frustration competing with dip-buying and long-term bullish hopes. Some traders connect the weakness to broader crypto-market pressure, but no specific catalyst is clearly established.

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

Mineralys Therapeutics Inc

AstraZenecas early Baxfendy launch and limited payer coverage have fueled concern that uptake of aldosterone-synthase inhibitors may ramp slowly, weighing on expectations for Mineralys lorundrostat. Traders debate whether this is an early access issue or a sign that MLYS could struggle to compete commercially on its own, with a broad market sell-off also cited as pressure.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

FDA accelerated approval of Inovios competing RRP treatment, Voceryq, has intensified concerns about competition for Precigens PAPZIMEOS and coincided with a sharp after-hours pullback. Traders debate how much of a threat the rival poses, weighing its potential to reduce surgeries against Precigens first-mover commercial lead and Inovios remaining launch and confirmatory-trial requirements.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick is drawing attention amid a pullback in gold miners, with bearish chart commentary and put-heavy options flow fueling concern that the decline may continue. Bullish traders see the weakness as a correction in a longer-term precious-metals uptrend and are adding to positions.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvuss presentation of early soquelitinib data in atopic dermatitis is driving discussion, with bullish traders viewing the results as promising while skeptics question their strength and safety given the early-stage evidence. The shares sold off after the event, which some traders attribute to elevated expectations and a presentation they felt offered too little new information.

Direxion Shares ETF Trust - Direxion Daily MU Bull 2X ETF

Direxion Daily MU Bull 2X Shares

MUU is drawing attention amid a sharp, volatile pullback in Micron and memory stocks, amplified by the funds 2 daily leverage. Traders are divided between buying the dip for a rebound and waiting for further downside, with some pointing to broader semiconductor weakness and market concerns while others view the selloff as temporary; the funds 20-for-1 split has also caused confusion.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

A sharp volatility spike has driven UVIX higher, with traders linking the move to market weakness and concerns around oil, interest rates, and geopolitical risk. Some are adding volatility hedges and celebrating the return of market fear, while others warn the leveraged ETF can quickly lose value through decay and expect the spike to fade.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

LGAR News